Ryan Govender
Chief Executive Officer at TREATT PLC
Net worth: 719 $ as of 2024-03-30
Profile
Ryan Govender is currently the Chief Executive Officer, Secretary & Director at Treatt Plc.
He previously worked as the Chief Financial Officer at SPI Pharma, Inc.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-06-19 | 973 ( 0.00% ) | 574 $ | 2024-03-30 | |
TREATT PLC
0.00% | 2024-03-13 | 27 ( 0.00% ) | 145 $ | 2024-03-30 |
Ryan Govender active positions
| Companies | Position | Start |
|---|---|---|
| TREATT PLC | Chief Executive Officer | 2023-12-31 |
Former positions of Ryan Govender
| Companies | Position | End |
|---|---|---|
SPI Pharma, Inc.
 SPI Pharma, Inc. Pharmaceuticals: MajorHealth Technology Part of The Garfield Weston Foundation, SPI Pharma, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in Wilmington, DE. The CEO of the company is Scott Thomson. | Director of Finance/CFO | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| TREATT PLC | Process Industries |
| Private companies | 1 |
|---|---|
SPI Pharma, Inc.
SPI Pharma, Inc. Pharmaceuticals: MajorHealth Technology Part of The Garfield Weston Foundation, SPI Pharma, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in Wilmington, DE. The CEO of the company is Scott Thomson. | Health Technology |
- Stock Market
- Insiders
- Ryan Govender
